By Sheri Kasprzak
New York, March 16 - Nanogen, Inc. said it is gearing up to complete a $15 million direct placement.
The company will sell 5,660,377 shares at $2.65 each to Fisher Scientific International Inc.
The deal was slated to close Thursday evening.
The shares will be sold under the company's shelf registration.
Based in San Diego, Nanogen produces diagnostic tests used by researchers, clinicians and physicians.
| Issuer: | Nanogen, Inc.
|
| Issue: | Stock
|
| Amount: | $15 million
|
| Shares: | 5,660,377
|
| Price: | $2.65
|
| Warrants: | No
|
| Investor: | Fisher Scientific International Inc.
|
| Settlement date: | March 16
|
| Stock symbol: | Nasdaq: NGEN
|
| Stock price: | $2.52 at close March 15
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
